Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-sirolimus + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer
NCT03439462Phase 2Completed
- Sponsor
- Aadi Bioscience, Inc.
- Start
- Jul 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in colorectal cancer (metastatic) (mCRC), sponsored by Aadi Bioscience, Inc.. Started Jul 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03439462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439462.